In recent years, LIM domains-containing protein 1 (LIMD1) has been identified as a critical component in microRNA (miRNA)-induced silencing complex (miRISC) to regulate miRNA-mediated gene silencing. Human Argonaute (AGO) 2 with its family members (AGO1-4) are critical for the biogenesis of miRNA and thus miRNA-mediated gene silencing. In this study, we have investigated the direct interaction interfaces between LIMD1 and AGO2. A distinct interface within LIMD1, amino acid (a.a) 140-166, is identified to be responsible for the binding to AGO2 and other members of AGO family. Furthermore, the Linker-2 (L2) domain within AGO2 is identified to be responsible for LIMD1 binding and its dependency on the phosphorylation at serine 387 (S387) residue within the L2 domain of AGO2. The phospho-mimic mutant (S387E) enhances the binding of AGO2 to LIMD1, whereas the phospho-deficient mutant (S387A) attenuates AGO2-LIMD1 interaction. In addition, the association of LIMD1 with other AGOs is also dependent on the phosphorylation at the equivalent conserved serine residue within the L2 domain on other AGOs. In addition to the above aspects, LIMD1 is a tumour suppressor gene frequently down-regulated in more than 75% human lung tumours. Because of their loss of expressions or functions, it is of the inherent difficulty in targeting tumour suppressor genes to treat cancers. In this study, the concept of synthetic lethality was used to identify possible protein kinases, the ablation of which are synthetically lethal to LIMD1 negative cancer cell lines. As a result, drugs that target these kinases may represent novel targeted therapies for LIMD1 negative lung tumours. ACVR2B and STK39 are validated to be synthetically lethal with LIMD1 loss. Additionally, the complete loss of LIMD1 expression causes a dramatic increase of STK39 expression due to miRNA-mediated gene silencing pathway. The inverse relationship between LIMD1 and STK39 may represent a conserved and fundamental signalling response and may be a predictive marker for STK39-targeted therapy.

MicroRNAs (miRNAs) sind kurze nicht-kodierende RNAs, die auf posttranskriptionaler Ebene die Genexpression hemmen. Dafür bilden miRNAs Ribonukleoprotein-Komplexe, deren Kernbestandteile aller Bilateria Argonaute (AGO) und GW182 /TNRC6 Proteine sind. GW182 / TNRC6-Proteine rekrutieren CCR4-NOT-Deadenylasen über kurze Tryptophan-reiche Motive (W-Motive), welche additiv wirken und fördern so die translationale Repression und den Abbau von Ziel-mRNAs. Um mehr über die Mechanismen der miRNA-abhängigen Genrepression zu erfahren, habe ich W-Motiv-abhängige Interaktionspartner humaner TNRC6C Proteine bestimmt. Hierzu habe ich, mithilfe von quantitativer Massenspektrometrie, das Interaktom von wildtyp TNRC6C Proteinen mit dem von TNRC6C Proteinen, deren W-Motive mutiert wurden, verglichen. Neben bekannten Interaktionspartnern, wie Untereinheiten des CCR4-NOT Komplexes, habe ich Komponenten von Clathrin-Vesikeln (CCVs), Stoffwechsel assoziierte Enzyme, mitochondriale Proteine, RNA Helikasen, Kinasen und Phosphatasen mit potentiellen Funktionen in der miRNA-assoziierten Repression identifiziert. Die im ersten Teil dieser Studie vorgestellten Ergebnisse legen nahe, dass CCVs die Speicherung oder das Recycling von TNRC6 und AGO Proteinen vermitteln können und somit das miRNA-Silencing modulieren. Der zweite Teil dieser Studie befasst sich mit der Konservierung von miRNA vermitteltem Gen-Silencing in Cnidaria (Nematostella vectensis), welche sich vor 600 Millionen Jahren von der Ahnenreihe der Metazoa abspalteten. Hier zeige ich anhand humaner Zellen, dass Nematostella GW182, ähnlich wie in Bilateria, von AGO rekrutiert wird und nachfolgend in der Repression der mRNA fungiert, was darauf hinweist, dass dieser Mechanismus der miRNA-vermittelten Geninhibition bereits in den letzten gemeinsamen Vorfahren von Cnidaria und Bilateria aktiv war. / MicroRNAs (miRNAs) are short non-coding RNAs that act as post-transcriptional repressors of gene expression. To function miRNAs are assembled in ribonucleoprotein complexes, whose core components in bilaterian animals are Argonaute (AGO) and GW182/TNRC6 proteins. GW182/TNRC6 proteins additively recruit CCR4-NOT deadenylases via short tryptophan-containing motifs (W-motifs), thereby promoting translational repression and the decay of target mRNAs. To gain deeper insights into the mechanisms of miRNA silencing I determined the W-motif-specific interactome of human TNRC6C proteins. Using Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) coupled to affinity purification and Mass Spectrometry (MS) I identified proteins enriched with wild type TNRC6C as compared to two mutants with disrupted W-motifs. Besides known functional interactors, such as subunits of the CCR4-NOT complex, I identified several components of clathrin-coated vesicles (CCVs), metabolic enzymes, mitochondrial proteins, RNA helicases, kinases, and phosphatases with potential functional roles in miRNA-mediated repression. The results presented in the first part of this thesis indicate that CCVs may mediate the storage or recycling of TNRC6 and AGO proteins, thus modulating miRNA silencing. The second part of the thesis addressed the conservation of the mechanisms of miRNA silencing via W-motifs in the cnidarian Nematostella vectensis, separated by 600 million years from other Metazoa. Using cultured human cells, I showed that similarly to bilaterians, GW182 in Nematostella is recruited to the miRNA repression complex via interaction with AGO proteins, and functions downstream to repress mRNA, indicating that this mechanism of miRNA-mediated silencing was already active in the last common ancestor of Cnidaria and Bilateria.